B Ferger, C Spratt, P Teismann, G Seitz, K Kuschinsky
Index: Eur. J. Pharmacol. 360(2-3) , 155-63, (1998)
Full Text: HTML
The potential new iron-chelator cytisine and the radical scavenger N-tert-butyl-alpha-(2-sulfophenyl) nitrone (S-PBN) were incubated in a Fenton system and hydroxyl radical formation was measured with the salicylate trapping assay. Both cytisine and S-PBN reduced hydroxyl radical formation in a concentration-dependent manner. For in vivo studies, C57BL/6 mice were injected repeatedly with cytisine (0.5 mg/kg or 2.0 mg/kg s.c.) or saline seven days before and after a single 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) injection (30 mg/kg s.c.). Seven days after MPTP treatment alone dopamine levels were significantly reduced to 12% of the control values (p < 0.001), whereas MPTP + cytisine treatment (2 mg/kg) led to more than twofold higher dopamine levels (p < 0.01) compared with MPTP alone. We have shown for the first time that cytisine attenuates hydroxyl radical formation in vitro and reduces MPTP-induced dopamine depletion. Thus, cytisine may be useful for the treatment of Parkinson's Disease where the chelation of iron ions could prevent neuronal cell death.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
N-tert-Butyl-α-(2-sulfophenyl)nitrone sodium salt
CAS:73475-11-3 |
C11H14NNaO4S |
Atypical effect of some spin trapping agents: reversible inh...
2000-02-15 [Free Radic. Biol. Med. 28(4) , 597-603, (2000)] |
Comparison of the radical trapping ability of PBN, S-PPBN an...
2001-04-01 [Free Radic. Res. 34(4) , 417-26, (2001)] |
The free radical scavenger S-PBN significantly prolongs DSG-...
2012-01-01 [Xenotransplantation 19(3) , 166-76, (2012)] |
Lipoic acid improves survival in transgenic mouse models of ...
2001-10-29 [Neuroreport 12(15) , 3371-3, (2001)] |
Comparison of neuroprotective effects induced by alpha-pheny...
2005-12-01 [Neurotoxicology 26(6) , 969-79, (2005)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved